: Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt
: Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt
: Phosphoinositide 3-kinase in Health and Disease Volume 1
: Springer-Verlag
: 9783642136634
: 1
: CHF 200.50
:
: Nichtklinische Fächer
: English
: 310
: Wasserzeichen/DRM
: PC/MAC/eReader/Tablet
: PDF
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here we give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here
Contents6
Contributors8
Introduction12
1 Establishing Order Within the Cell12
2 Phosphatidylinositol and Phosphoinositides as Ideal Substrates13
3 Nucleating a Protein Complex at a Target Location14
4 Coupling PI3K Activity to Extracellular Cues14
5 Disease Implications16
References17
PDK1: The Major Transducer of PI 3-Kinase Actions19
1 Introduction20
2 Mechanism of Activation of the AGC Kinases20
2.1 PDK1, the Common T-Loop Kinase21
2.2 mTORC1 and mTORC2, the Hydrophobic Motif Kinases22
2.3 Two Mechanisms of Regulation by PDK124
3 Structure of PDK126
4 Genetic Models and Disease27
4.1 PDK1 and Diabetes27
4.2 PDK1 and T-Cell Development29
4.3 PDK1, Growth and Cancer29
5 PDK1 as a Druggable Target30
6 Concluding Remarks32
References33
Protein Kinase B (PKB/Akt), a Key Mediator of the PI3K Signaling Pathway40
1 Classification, Structure, and Substrates of PKB41
2 Regulation of PKB Activity42
2.1 Regulation of PKB Activity by Phosphorylation Events42
2.2 Regulation of PKB Activity by Binding Partners44
2.2.1 PKB Activators45
2.2.2 PKB Inhibitors47
2.2.3 PKB-Interacting Proteins with Undefined Functions47
2.3 Regulation of PKB by CTMP48
3 The Role of PKB in Physiological and Pathological Conditions49
3.1 Effects of Knocking-Out Individual PKB Isoforms in Mice50
3.2 PKB in Embryonic Development50
3.3 PKB in Thymocyte Development51
3.4 PKB in Adipocyte Differentiation52
3.5 PKB in Glucose Homeostasis53
3.6 PKB in Tumor Formation55
4 Conclusion56
References57
PI3Ks in Lymphocyte Signaling and Development66
1 Introduction68
2 PI3K in B Cells71
2.1 B-Cell Development71
2.2 BcR Signaling, Antigen Presentation, and Metabolism72
2.3 Immunoglobulin Gene Rearrangement and Isotype Switching74
2.4 B-Cell Chemotaxis and Trafficking76
3 PI3K in T Cells76
3.1 T-Cell Development and Differentiation76
3.1.1 A Surprising Redundancy Between p110delta and p110gamma During T-Cell Development76
3.2 TcR Signaling and Costimulation77
3.2.1 PI3K Regulates Some, But Not All, TcR-Dependent Signaling Pathways79
3.3 T-Helper Cell Differentiation80
3.4 Survival and Glucose Homeostasis in Mature T cells81
3.5 PI3K Controls the Development and Suppressive Function of Regulatory T Cells81
3.6 T-Cell Chemotaxis and Migration in Lymph Nodes: Not All About PI3K83
3.7 T-Cell Trafficking84
3.8 Nonessential Role for PI3K in Cytotoxic Responses85
4 Prospects for PI3K Inhibitors in Inflammation and Autoimmunity85
References86
The Regulation of Class IA PI 3-Kinases by Inter-Subunit Interactions95
1 Structural Organization of p85a/p110a96
2 p85a Inhibits and Stabilizes p11098
3 Activation of p85a/p110a Dimers by Phosphopeptides100
4 A Mechanism for Phosphopeptide Activation101
5 Activation of p85/p110 by GTPases104
6 Activation by Binding to p85 SH3 and Proline-Rich Domains107
7 Regulation by Autophosphorylation107
8 Oncogenic Mutation of p85a and p110108
8.1 Helical Domain Mutants: Disruption of the nSH2-Helical Domain Interface109
8.2 The Kinase Domain Mutant H1047R110
8.3 p110a Mutations Disrupting the C2-iSH2 Domain Interface110
8.4 p85a Mutations Disrupting the C2-iSH2 Domain Interface111
9 Regulation of p85/p110 In vivo: Activation Versus Translocation112
10 Unanswered Mechanistic Questions on p85-p110 Interactions113
References115
Phosphoinositide Signalling Pathways in Metabolic Regulation123
1 Introduction124
2 Role of Insulin Signalling Network Molecules in Metabolic Regulation as Revealed by Global Gene Inactivation in Mice125
3 Role of INSR/PI3K Pathway Components in the Development and Function of Insulin Sensitive Tissues131
3.1 Insulin Sensitive Peripheral Tissues131
3.2 Pancreatic Islets134
3.3 Central Nervous System137
4 Role of the INSR/PI3K Pathway in the Integration of Nutrient Availability and Growth Factor/Hormonal Signals139
5 Molecular Basis of Insulin Resistance Development: Signal Termination Feedback Loops140
6 Discussion141
References142
Role of RAS in the Regulation of PI 3-Kinase150
1 RAS Proteins151
2 RAS Effectors153
3 RAS-PI3K Interaction157
4 RAS-PI3K in Normal Signalling158
5 RAS-PI3K in Oncogenesis160
6 RAS-PI3K-RAF Pathway Interconnections164
7 Inhibitors167
8 Conclusions168
References169
More Than Just Kinases: The Scaffolding Function of PI3K177
1 The Double Identity of PI3Kgamma178
1.1 Cardiomyocytes179
1.2 Circulating Endothelial Progenitor Cells179
1.3 Platelets180
2 The Double Identity of PI3Kbeta180
2.1 Cell Growth180
2.2 Metabolism182
2.3 Oncogenesis183
3 The Double Identity of Adaptor Subunits183
4 Conclusions184
References185
PI3K Signaling in Neutrophils188
1 Neutrophil Biology189
2 Regulation of PI3Ks192
3 Regulation of PtdIns(3,4,5)P3195
4 Effectors of PI3K Signaling Pathways195
5 Class I PI3K Regulation of Rho Family GTPases in the Context of Cell Spreading and Movement196
6 Class I and Class III PI3K Regulation of the NADPH Oxidase198
7 PI3Ks in Neutrophils as Therapeutic Targets201
8 Conclusions202
References202
PI 3-Kinase p110beta Regulation of Platelet Integrin aIIbbeta3208
1 Introduction209
2 Basic Principles of Platelet Adhesion and Activation210
3 Integrin aIIb